Drug recall · December 5, 2012
Advair HFA recall
Why: Product Lacks Stability: These lots are being recalled due to the failure to meet the particle size distribution specification.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Advair HFA (fluticasone propionate/salmeterol) Inhalation Aerosol, 45mcg/21 mcg 60 Actuations INST, NDC 0173-0715-22, Rx only, GlaxoSmithKline, Research Triangle Park, NC 27709.
- Lots / codes
1ZP3065, Exp. Oct-12, 1ZP5453, Exp. Dec-12, 1ZP3315, Exp. May-13, 2ZP9974, Exp. Sep-13.
- Quantity
- 18,676 Aerosol Units
- Company
- GlaxoSmithKline, LLC., Zebulon, NC
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- October 24, 2012 · Voluntary: Firm initiated
- Classified
- November 23, 2012
- Reported
- December 5, 2012
- Ended
- September 11, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Advair
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.